γ-H2AX: A Novel Prognostic Marker in a Prognosis Prediction Model of Patients with Early Operable Non-Small Cell Lung Cancer

por Chatzimichail, E., Matthaios, D., Bouros, D., Karakitsos, P., Romanidis, K., Kakolyris, S., Papashinopoulos, G., Rigas, A.
Publicado 2014

Concurrent administration of Docetaxel and Stealth® liposomal doxorubicin with radiotherapy in non-small cell lung cancer : excellent tolerance using subcutaneous amifostine for cy...

por Koukourakis, M I, Romanidis, K, Froudarakis, M, Kyrgias, G, Koukourakis, G V, Retalis, G, Bahlitzanakis, N
Publicado 2002